0000899140-24-000705.txt : 20240710
0000899140-24-000705.hdr.sgml : 20240710
20240710111145
ACCESSION NUMBER: 0000899140-24-000705
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240623
FILED AS OF DATE: 20240710
DATE AS OF CHANGE: 20240710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DONG-A ST CO., LTD
CENTRAL INDEX KEY: 0001799260
ORGANIZATION NAME:
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 241109117
BUSINESS ADDRESS:
STREET 1: 64, CHEONHO-DAERO
STREET 2: DONGDAEMUN-GU
CITY: SEOUL
STATE: M5
ZIP: 02587
BUSINESS PHONE: 82-2-920-8184
MAIL ADDRESS:
STREET 1: 64, CHEONHO-DAERO
STREET 2: DONGDAEMUN-GU
CITY: SEOUL
STATE: M5
ZIP: 02587
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4/A
1
form4.xml
X0508
4/A
2024-06-23
2024-06-25
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001799260
DONG-A ST CO., LTD
64, CHEONHO-DAERO
DONGDAEMUN-GU
SEOUL
M5
02587
KOREA, REPUBLIC OF
true
false
Common Stock
2024-06-23
4
P
0
2544530
3.93
A
5348229
D
This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share.
Dong-A St Co., Ltd.; By: /s/ Min Young Kim, Chief Executive Officer
2024-07-10